To ask the Secretary of State for Health and Social Care, what assessment his Department has made of NICE’s ability to offer interim conditional reimbursement decisions to gene therapies that would allow for real-world evidence generation to supplement the evidence base.
Answered on
9 September 2019
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Answered by
Department of Health and Social Care